| NCT01446640 | Mesenchymal Stem Cells Transplantation to Patients With Spinal Cord Injury | Guangzhou General Hospital of Guangzhou Military Command | | - Age 16 - 60 yrs
- Level T1-L5
AIS A, B- 2 weeks - 1 years
| | 20 | PHASE1, PHASE2 | Biological/cell based | General health | | | 01 October 2011 | 05 October 2011 | 1 | |
| NCT01943669 | Exoskeletons for Spinal Cord Injury: A Feasibility Study | Buckinghamshire Healthcare NHS Trust | | - Age 18 - 55 yrs
- Level C7-L1
AIS A, B, C- 12 months - 55 years
| | 10 | PHASE4 | Technology | Standing/walking/mobility | | | 01 June 2013 | 17 September 2013 | 1 | |
| NCT02034669 | Transplantation of Autologous Adipose Derived Stem Cells (ADSCs) in Spinal Cord Injury Treatment | Tri Phuoc Biotechnology., JSC | | - Age 19 - 60 yrs
- Level C1-S5
AIS A- ≤ 2 weeks
| | 48 | PHASE1, PHASE2 | Biological/cell based | General health | | | 01 February 2013 | 13 January 2014 | 1 | |
| NCT02118194 | Home/Work, Community Mobility Skills in the ReWalk Exoskeleton in Persons With SCI | James J. Peters Veterans Affairs Medical Center | | - Age 18 - 65 yrs
- Level T1-S5
AIS A, B, C, D- ≤ 65 years
| Ended | 5 | | Technology | Standing/walking/mobility | | | 01 October 2013 | 21 April 2014 | 2 | |
| NCT02136823 | Impact of Persistent Conductances on Motor Unit Firing in SCI | Shirley Ryan AbilityLab | | - Age 18 - 65 yrs
- Level C5-T1
AIS C, D- 1 years - 65 years
| | 50 | NA | Drug | Spasticity | | | 01 June 2009 | 13 May 2014 | 0 | |
| NCT02138110 | The INSPIRE Study: Probable Benefit of the Neuro-Spinal Scaffold for Treatment of AIS A Thoracic Acute Spinal Cord Injury | InVivo Therapeutics | | - Age 16 - 70 yrs
- Level T2-L1
AIS A- ≤ 96 hours
| Ended | 20 | NA | Surgery | General health | | | 13 October 2014 | 14 May 2014 | 8 | |
